Infantile liver failure

At a Glance

Infantile liver failure is a disease concept referring to a state of liver dysfunction occurring in infants.

Jaundice, bleeding, hypoglycemia, abdominal distension, vomiting, lethargy, or changes in consciousness may occur.

How the Disease Works

Causes can vary, including hereditary metabolic diseases, infections, exposure to toxic substances or drugs, and hypoxic injury.

When hepatocytes are damaged or liver function declines, the production of substances necessary for detoxification, protein synthesis, blood glucose regulation, and blood coagulation may be insufficient.

Patterns Vary by Person

Risks and prognosis may vary depending on the infant's age, underlying genetic disease, history of infection or exposure, nutritional status, and whether there is damage to other organs.

Broad framework of diagnosis and management

The condition can deteriorate rapidly, but depending on the cause and response to treatment, it may recover or lead to chronic liver disease.

Diagnosis is made by comprehensively combining blood tests for liver function, coagulation, and metabolism, infection tests, imaging, and genetic/metabolic evaluation as necessary, based on medical history and physical examination.

Current stage of treatment

Since it is difficult to determine severity or cause based on liver enzyme levels alone, test results must be interpreted in conjunction with the infant's age, changes in symptoms, the timing of the test, and overall condition.

Management focuses on treating the underlying cause, along with promptly identifying hypoglycemia, bleeding, infection, electrolyte abnormalities, and changes in brain function, and providing necessary supportive care.

Treatment varies depending on the cause and the possibility of recovery; in severe cases, specialized liver disease care, pediatric intensive care, and liver transplant evaluation may be considered.

How to read clinical trials

Follow-up involves monitoring liver function, growth and nutritional status, neurodevelopment, and post-treatment complications; effectiveness or whether it is standard treatment should not be judged solely by participation in or registration in clinical trials.

Points to verify in clinical encounters

In clinical practice, it is important to assess the onset of symptoms, feeding and growth status, family history, exposure to infections, medications, or toxic substances, changes in laboratory values, and whether specialized liver disease consultation is necessary.